| Colorectal cancer liver metastases - a population-based study on incidence, management and survival |
73 |
| N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer |
45 |
| Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study |
40 |
| Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins |
38 |
| Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models |
37 |
| Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States |
36 |
| Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling |
32 |
| MicroRNAs as markers of progression in cervical cancer: a systematic review |
31 |
| Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial |
30 |
| The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study |
30 |
| A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK |
29 |
| Mechanisms of immune evasion in breast cancer |
28 |
| Changes of N6-methyladenosine modulators promote breast cancer progression |
28 |
| Curcumin inhibits proliferation, migration, invasion and promotes apoptosis of retinoblastoma cell lines through modulation of miR-99a and JAK/STAT pathway |
27 |
| Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue |
27 |
| Survival and clinical outcomes of patients with melanoma brain metastasis in the era of checkpoint inhibitors and targeted therapies |
26 |
| Mechanism of recipient cell-dependent differences in exosome uptake |
26 |
| Circular RNA: new star, new hope in cancer |
26 |
| Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis |
26 |
| Randomized prospective phase III trial of Ga-68-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT] |
26 |
| Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation |
25 |
| An elevated expression of serum exosomal microRNA---451a of pancreatic neoplasm is considered to be efficient diagnostic marker |
25 |
| Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma |
25 |
| Attributable causes of colorectal cancer in China |
25 |
| Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies |
25 |
| Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority |
24 |
| Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer |
24 |
| microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1 |
24 |
| CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer |
23 |
| Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps |
23 |
| An implementation of normal distribution based segmentation and entropy controlled features selection for skin lesion detection and classification |
23 |
| Association of tamoxifen resistance and lipid reprogramming in breast cancer |
23 |
| Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients |
22 |
| Using Resistin, glucose, age and BMI to predict the presence of breast cancer |
22 |
| Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials |
21 |
| Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA |
21 |
| miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study |
21 |
| A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer |
21 |
| Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy |
20 |
| The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases |
20 |
| EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer |
20 |
| Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab |
20 |
| Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China |
20 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial |
20 |
| Molecular Pathogenesis of Cholangiocarcinoma |
19 |
| Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis |
19 |
| Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer |
19 |
| Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells |
19 |
| Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients |
19 |
| Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter? |
18 |
